We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease
PeriodicalsMedical Sciences

Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease

Checking your access to this record.

Abstract & Overview

Metabolomics is a field of systems biology that draws on the scientific methods of other groups to qualitatively or quantitatively characterize small molecule metabolites in organisms, revealing their interconnections with the state of the organism at an overall relative macroscopic level. Diabetic kidney disease (DKD) is well known as a chronic metabolic disease, and metabolomics provides an excellent platform for its clinical study. A growing number of metabolomic analyses have revealed that individuals with DKD have metabolic disturbances of multiple substances in their bodies. With the continuous development and improvement of metabolomic analysis technology, the application of metabolomics in the clinical research of DKD is also expanding. This review discusses the recent progress of metabolomics in the early diagnosis, disease prognosis, and pathogenesis of DKD at the level of small molecule metabolites in vivo.

Cite this record

Guoqing Huang, Mingcai Li, Yan Jun Li, Yushan Mao (2022). Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease. Laboratory Medicine, 53(6), 545–551. https://doi.org/10.1093/labmed/lmac041

Copy in another style

Huang, G., Li, M., Li, Y. J., & Mao, Y. (2022). Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease. Laboratory Medicine, 53(6), 545–551. https://doi.org/10.1093/labmed/lmac041
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.